GENCODE: comprehensive genome annotation for human and mouse
GENCODE:人类和小鼠的全面基因组注释
基本信息
- 批准号:9277658
- 负责人:
- 金额:$ 263.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingBiologicalBiomedical ResearchClassificationClinicalCodeCommunitiesComplementary DNAComputing MethodologiesDataData SetDiseaseEnhancersEnsureFoundationsGenesGenetic TranscriptionGenomeGenomic approachGenomicsGenotype-Tissue Expression ProjectGoalsGraphHaplotypesHealthHumanHuman GenomeIndividualInformaticsInvestigationKnock-outKnowledgeLengthManualsMass Spectrum AnalysisMethodsModelingMouse StrainsMusNucleic Acid Regulatory SequencesPilot ProjectsPolymerasePopulationProtein IsoformsProteinsPseudogenesPublic HealthQuality ControlRNARecruitment ActivityResearchResearch DesignSeriesSourceTechnologyTissuesTranscriptTranscription InitiationUntranslated RNAValidationbaseepigenomeevidence basegenome annotationgenome browsermouse genomenew technologynovelpopulation basedreference genometooltranscriptometranscriptome sequencingtranscriptomicsweb site
项目摘要
OVERALL - PROJECT SUMMARY
The objective of the GENCODE consortium is to create a foundational reference genome
annotation, in which all gene features in the human and mouse genomes are identified and
classified with high accuracy based on biological evidence, and then to release these
annotations for the benefit of biomedical research and genome interpretation. GENCODE aims
for a better understanding of a `normal' human genome; using genome sequences of the most
commonly used mouse strains will facilitate the most effective use of these key models for
large-scale knockout analysis and disease-specific research. To produce regular annotation
releases of high accuracy, GENCODE will continue to follow its well-established and
conservative research design, supplemented by targeted investigations into the value of new
technologies, new data and new sources of evidence. GENCODE focuses on protein-coding
and non-coding loci, including their alternatively spliced isoforms and pseudogenes. Over the
course of this proposal GENCODE will follow major directions in genomics, including graph-
based genome representations, long-read transcriptome sequencing, connecting genes and the
associated regulatory regions that affect their transcription, and identifying genes that are not
present on the current reference assembly. The GENCODE consortium has four fundamental
components: (1) a comprehensive gene annotation pipeline leveraging manual annotation; (2)
an integrated approach to pseudogene identification and classification; (3) a set of
computational methods to evaluate and enhance gene annotation; and (4) complementary
experimental pipelines for validation and functional annotation. More specifically, in the next four
years GENCODE aims to (1) extend the human and mouse GENCODE gene sets to as near
completion as possible given current experimental technology; (2) deploy population-based
genome annotation to ensure that any transcript isoform expressed in an individual human will
be present in the reference annotation set; (3) extend the gene annotation to include core
regulatory regions and tissue-specific enhancers from selected datasets; (4) to distribute
GENCODE annotations and engage with community annotation efforts. Current popular
distribution channels for GENCODE data including the GENCODE web site, the Ensembl and
UCSC Genome Browsers, will be maintained. Finally, new mechanisms for prioritizing genes for
manual annotation with community input will be established, with the long-term aim of
establishing GENCODE as the standard annotation set for research and clinical genomics
efforts.
总体-项目摘要
GENCODE联盟的目标是创建一个基础参考基因组
注释,其中鉴定人和小鼠基因组中的所有基因特征,
根据生物证据进行高精度分类,然后发布这些
注释,以利于生物医学研究和基因组解释。GENCODE目标
为了更好地了解“正常”的人类基因组;使用大多数人的基因组序列
常用的小鼠品系将有助于最有效地使用这些关键模型,
大规模基因敲除分析和疾病特异性研究。生成规则注释的步骤
发布的高精度,GENCODE将继续遵循其良好的,
保守的研究设计,辅之以有针对性的调查新的价值,
技术、新数据和新证据来源。GENCODE专注于蛋白质编码
和非编码基因座,包括它们的可变剪接同种型和假基因。来
GENCODE将遵循基因组学的主要方向,包括图表,
基于基因组表示,长读转录组测序,连接基因和
相关的调控区,影响其转录,并确定基因,
当前参考程序集上存在的。GENCODE联盟有四个基本的
组件:(1)利用手动注释的综合基因注释管道;(2)
假基因鉴定和分类的综合方法;(3)一套
评估和增强基因注释的计算方法;以及(4)互补
用于验证和功能注释的实验管道。更具体地说,在接下来的四年里
2010年GENCODE的目标是(1)将人类和小鼠的GENCODE基因集扩展到尽可能接近
在现有实验技术条件下尽可能完成;(2)部署基于人口的
基因组注释以确保在个体人类中表达的任何转录物同种型将
存在于参考注释集中;(3)扩展基因注释以包括核心
调控区和组织特异性增强子;(4)分布
GENCODE注释并参与社区注释工作。当前流行
GENCODE数据的分发渠道,包括GENCODE网站、Ensembl和
将维护UCSC基因组浏览器。最后,优先考虑基因的新机制,
将建立社区输入的手动注释,长期目标是
建立GENCODE作为研究和临床基因组学的标准注释集
努力
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Flicek其他文献
Paul Flicek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Flicek', 18)}}的其他基金
The WashU-UCSC-EBI Human Genome Reference Center."
华盛顿大学-UCSC-EBI 人类基因组参考中心。”
- 批准号:
10419218 - 财政年份:2021
- 资助金额:
$ 263.83万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
10219322 - 财政年份:2019
- 资助金额:
$ 263.83万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
10020425 - 财政年份:2019
- 资助金额:
$ 263.83万 - 项目类别:
The WashU-UCSC-EBI Human Genome Reference Center
华盛顿大学-UCSC-EBI 人类基因组参考中心
- 批准号:
9906005 - 财政年份:2019
- 资助金额:
$ 263.83万 - 项目类别:
GENCODE: comprehensive reference genome annotation for human and mouse
GENCODE:人类和小鼠的综合参考基因组注释
- 批准号:
10186568 - 财政年份:2013
- 资助金额:
$ 263.83万 - 项目类别:
GENCODE: comprehensive genome annotation for human and mouse
GENCODE:人类和小鼠的全面基因组注释
- 批准号:
9980954 - 财政年份:2013
- 资助金额:
$ 263.83万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 263.83万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 263.83万 - 项目类别:
Research Grants














{{item.name}}会员




